IRRAS0,177 SEK −1,61 %
IRRAS is a medical technology company. The company is focused on developing solutions for surgical procedures for brain diseases. The company has currently developed a technological platform that focuses on the management of a number of components in hemorrhagic stroke and chronic subdural hematoma, mainly in fluid management and intracranial hemorrhage. The company is headquartered in Stockholm.